Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2018, Vol. 9 Issue (4) : 748-754     DOI: 10.14336/AD.2017.1003
Short Communication |
Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects
Vinagre Carmen G1,2, Freitas Fatima R1, de Mesquita Carlos H3, Vinagre Juliana C1, Mariani Ana Carolina2, Kalil-Filho Roberto1, Maranhão Raul C1,4,*
1Heart Institute (InCor) of Medical School Hospital, University of São Paulo, São Paulo, Brazil.
2University of Santo Amaro, São Paulo, Brazil
3Institute of Nuclear Research, University of São Paulo, São Paulo, Brazil
4Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Download: PDF(542 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Dietary fats absorbed in the intestine are transported in the circulation as chylomicrons and remnants that have atherogenic potential. Although postprandial lipidemia is increased in older subjects, the specific chylomicron metabolism has not been explored in older subjects nor compared to young subjects, which is the focus of this study. After a 12 h fast, artificially-made emulsions similar to lymph chylomicrons and doubly labeled with radioactive cholesteryl esters and triglycerides were intravenously injected in 23 older (66±4 years) and 20 young (24±3 years) subjects. Sequential blood samples were collected to determine fractional clearance rates (FCR, in min-1) by compartmental analysis. Older subjects had higher LDL-cholesterol (p<0.001) and triglycerides (p<0.0001) than young subjects; HDL-cholesterol presented no difference. The emulsion cholesteryl-ester FCR was lower in older subjects compared to the young (p=0.0001). The emulsion triglyceride FCR did not differ in the two groups. Tested in vitro, however, the lipolysis of the emulsion triglycerides was less intense in the older than in the young subjects. As delayed removal of remnants, indicated by the pronouncedly smaller cholesteryl ester FCR, is related to the presence of cardiovascular diseases, this can be a risk factor which could accelerate atherogenic complications occurring in aged subjects

Keywords Aging and atherosclerosis      chylomicron remnants      cholesterol and aging      triglyceride      emulsions     
Corresponding Authors: Maranhão Raul C   
About author:

These authors equally contributed to this work.

Issue Date: 01 August 2018
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Vinagre Carmen G
Freitas Fatima R
de Mesquita Carlos H
Vinagre Juliana C
Mariani Ana Carolina
Kalil-Filho Roberto
Maranhão Raul C
Cite this article:   
Vinagre Carmen G,Freitas Fatima R,de Mesquita Carlos H, et al. Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects[J]. Aging and disease, 2018, 9(4): 748-754.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2017.1003     OR     http://www.aginganddisease.org/EN/Y2018/V9/I4/748
Young
(n=20)
Older
(n=23)
P
Age (years)24±366±4<0.0001
Gender (M/F)8/129/14>0.05
BMI (kg/cm2)23±325±40.8732
Glucose (mg/dL)79±984±70.05
Cholesterol (mg/dL)
 Total155±27196±450.0010
 HDL53±1148±120.1643
 LDL88±19124±420.0010
Triglycerides (mg/dL)58±24129±56<0.0001
In vitro lipolysis (AUC)5,681±1,9887,394±2,3090.0133
Table 1  Plasma lipids and in vitro lipolysis measured in subjects with age under 30 years (young group) and with more than 60 years (older group).
Figure 1.  Kinetic model employed for chylomicron-like emulsion metabolism <i>in vivo</i>

The observed data (compartments C1 and C2) present a biexponential curve. Compartments C1- C4 represent kinetics of 14C-cholesteryl oleate (14C-CE). Compartments C5 - C8 represent kinetics of 3H-triglycerides (3H-TG). Compartments C1 and C5 represent emulsion after plasma injection. Compartments C2 and C6 represent emulsion after redistribution. Compartments C3 and C7 correspond extra-vascular space, mainly the liver, and C4 and C8 the emulsion labeled lipids recirculation. The constants ki,j (min-1) represent the fractional catabolic rate (FCR) or transfer from compartment j to compartment i over time. k3,1 and k7,5 - fraction of injected emulsion that is removed directly from plasma by the liver and other tissues. k2,1 and k6,5 - emulsion transfer rates to a complex plasma lipoprotein pool. k3,2 and k7,6 - removal from the plasma of the emulsion mainly by the liver. k4,3 and k 8,7 - emulsion transfer rates to VLDL (labeled lipids recirculation). k3,4 and k7,8 - recirculated lipids removal by the liver. k0,4 and k0,8 - output of labeled lipids from the body.

Young
(n=20)
Older
(n=23)
P
k2,1 = k6,50.134±9.38x10-40.145±6.45x10-4<0.0001
k3,1 = k7,50.150±2,93x10-40.129±5.88x10-4<0.0001
k3,20.0216±0.00970.0155±7.07x10-30.0222
k4,30.00122±0.000420.00470±0.003850.0071
k3,42.72x10-6±0.009960.0321±0.0079<0.0001
k0,43.74x10-7±0.004480.00309±0.003690.0173
k7,60.0560±0.00070.0498±0.0005<0.0001
k7,80.0578±0.00450.0422±0.0038<0.0001
k8,70.00937±0.005610.00939±0.004710.9899
k0,84.21x10-7±0.004330.0160±0.0025<0.0001
14C-CE FCR (min-1)0.019±0.0100.008±0.0070.0001
3H-TG FCR (min-1)0.027±0.0140.030±0.0170.5350
Table 2  Kinetics and compartmental analysis parameters in subjects with age under 30 years (young group) and with more than 60 years (older group).
Figure 2.  Plasma decay curve of the emulsion cholesteryl esters (A) and triglycerides (B) in healthy subjects with age under 30 years (young) and those with age above 60 years (older). The chylomicron-like emulsion labeled with the radioactive lipids was injected intravenously after a 12 hour fast. Plasma samples were taken at regular intervals over 60 minutes to determine the radioactivity remaining in the plasma in a scintillation solution.
[1] Redgrave TG (1970). Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest, 49:465-71.
[2] Lambert JE, Parks EJ (2012). Postprandial metabolism of meal triglyceride in humans. Biochim Biophys Acta, 1821:721-6.
[3] Wilhelm MG, Cooper AD (2003). Induction of atherosclerosis by human chylomicron remnants: a hypothesis. J Atheroscler Thromb, 10:132-9.
[4] Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ (1988). Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res, 29: 469-79.
[5] Cassader M, Gambino R, Ruiu G, Marena S, Bodoni P, Pagano G (1996). Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects. Aging (Milano), 8: 421-8.
[6] Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC, Peelman F, et al. (2010). The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis, 211(1):1-8.
[7] Borel P, Mekki N, Boirie Y, Partier A, Alexandre-Gouabay MC, Grolier P, et al. (1998). Comparison of the postprandial plasma vitamin A response in young and older adults. J Gerontol A Biol Sci Med Sci, 53: B133-40.
[8] Relas H, Gylling H, Rajaratnam RA, Miettinen TA (2000). Postprandial retinyl palmitate and squalene metabolism is age dependent. J Gerontol A Biol Sci Med Sci, 55:B515-21.
[9] Hirata MH, Oliveira HC, Quintão EC, Redgrave TG, Maranhão RC (1987). The effects of Triton WR-1339, protamine sulfate and heparin on the plasma removal of emulsion models of chylomicrons and remnants in rats. Biochim Biophys Acta, 917:344-6.
[10] Maranhão RC, Feres MC, Martins MT, Mesquita CH, Toffoletto O, Vinagre CG, et al. (1996). Plasma kinetics of a chylomicron like emulsion in patients with coronary artery disease. Atherosclerosis, 126:15-25.
[11] Vinagre CG, Stolf NA, Bocchi E, Maranhão RC (2000). Chylomicron metabolism in patients submitted to cardiac transplantation. Transplantation, 69(4):532-7.
[12] Sposito AC, Santos RD, Hueb W, Ventura LI, Vinagre CG, Ramires JA, et al. (2002). LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, 161:447-53.
[13] Mangili OC, Moron Gagliardi AC, Mangili LC, Mesquita CH, Machado Cesar LA, Tanaka A, et al (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233(1): 319-25
[14] Redgrave TG, Zech LA (1987). A kinetic model of chylomicron core lipid metabolism in rats: the effect of a single meal. J Lipid Res, 28: 473-82.
[15] ICRP Publication 113 (2009). Education and training in radiological protection for diagnostic and interventional procedures. Ann ICRP, 39:7-68.
[16] Ehnholm C, Kuusi T (1986). Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol, 129:716-38.
[17] Vinagre JC, Vinagre CC, Pozzi FS, Zácari CZ, Maranhão RC (2014). Plasma kinetics of chylomicron-like emulsion and lipid transfers to high-density lipoprotein (HDL) in lacto-ovo vegetarian and in omnivorous subjects. Eur J Nutr, 53:981-7.
[18] Schwartz CC, Vanden Broek JM, Cooper PS (2004). Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J Lipid Res, 45: 1594-607.
[19] Krasinski SD, Cohn JS, Schaefer EJ, Russell RM (1990). Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins. J Clin Invest, 85(3):883-92.
[20] Puga GM, Meyer C, Everman S, Mandarino LJ, Katsanos CS (2011). Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins. Am J Physiol Endocrinol Metab, 301, E356-61.
[21] Jackson KG, Knapper-Francis JM, Morgan LM, Webb DH, Zampelas A, Williams CM (2003). Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men. Clin Sci (Lond), 105: 457-66.
[22] Milan AM, Nuora A, Pundir S, et al (2016). Older adults have an altered chylomicron response to a high-fat meal. Br J Nutr, 115:791-9.
[23] Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A (1993). Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest, 91:748-58.
[24] Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, et al. (1993). Contribution of apo B48 and apo B100 triglyceride-rich lipoproteins (TLR) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res, 34: 2033-40.
[25] Karpe F, Hellénius ML, Hamsten A (1999). Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metabolism, 48: 301-7
[26] Takeuchi N, Matsumoto A, Katayama Y, Arao M, Koga M, Nakao H, et al. (1983). Changes with aging in serum lipoproteins and apolipoprotein C subclasses. Arch Gerontol Geriatr, 2(1-2): 41-8.
[27] Nakajima K, Nakano T, Tokita Y, Nagamine T, Inazu A, Kobayashi J, et al. (2011). Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin Chim Acta. 412(15-16): 1306-18.
[28] Marino M, Pallottini V, D’Eramo C, Cavallini G, Bergamini E, Trentalance A (2002). Age-related changes of cholesterol and dolichol biosynthesis in rat liver. Mech Ageing Dev, 123:1183-9
[29] de Faria E, Fong LG, Komaromy M, Cooper AD (1996). Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J Lipid Res, 37: 197-209.
[30] Park Y, Damron BD, Miles JM, Harris WS (2001). Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. Lipids, 36(2): 115-20.
[1] Deng Qi-Wen, Li Shuo, Wang Huan, Lei Leix, Zhang Han-Qing, Gu Zheng-Tian, Xing Fang-Lan, Yan Fu-Ling. The Short-term Prognostic Value of the Triglyceride-to-high-density Lipoprotein Cholesterol Ratio in Acute Ischemic Stroke[J]. Aging and disease, 2018, 9(3): 498-506.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd